Showing results (591-600 of 5,929) with videos related to
Sort By:
Pageof 593
The Prostate|January 1, 1988
Application of octadecylsilyl-silica in purification studies related to the nontransformed rat ventral prostate androgen receptorM Koutsilieris, F Bouthillier, F Grondin, et al.The Prostate|May 9, 2017
The effect of non-steroidal anti-inflammatory drugs on risk of benign prostatic hyperplasiaLotta H Nygård, Kirsi Talala, Kimmo Taari, et al.The Prostate|April 15, 2018
Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counselingVeda N Giri, Elias Obeid, Sarah E Hegarty, et al.The Prostate|April 3, 2018
Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasiaSo Inamura, Hideaki Ito, Tomochika Shinagawa, et al.The Prostate|January 1, 1987
Long-term results with a long-acting formulation of D-TRP-6 LH-RH in patients with prostate cancer: an Italian prostatic cancer project (P.O.N.CA.P.) studyF Boccardo, A Decensi, D Guarneri, et al.The Prostate|January 1, 1987
Androgen action blockade does not result in reduction in size but changes histology of the normal human prostateH J de Voogt, B R Rao, A A Geldof, et al.The Prostate|January 1, 1993
Presence of 11 beta-hydroxysteroid dehydrogenase enzyme in the human prostate tumor cell line LNCaPN Nath, V Lakshmi, J C RosenthalThe Prostate|January 8, 2010
Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cellsMin Zhang, Michael Siedow, Gregory Saia, et al.The Prostate|December 25, 2009
Gestational and neonatal-onset hypothyroidism alters androgen receptor status in rat prostate glands at adulthoodMichael Maria Aruldhas, Neelamohan Ramalingam, Anbalagan Jaganathan, et al.The Prostate|January 21, 2010
Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell linesBreanne D W Karanikolas, Marxa L Figueiredo, Lily WuPageof 593